InvestorsHub Logo
Followers 0
Posts 307
Boards Moderated 0
Alias Born 07/28/2020

Re: None

Friday, 10/09/2020 8:33:33 AM

Friday, October 09, 2020 8:33:33 AM

Post# of 144814
PMCB cell encapsulation treatment Cyp Caps deemed
Ineffective by FDA in treating advanced LAPC.

THIS IS FACT.

If we are using statistical probabilities and associate the reduction of 4 tumors in patients from 20+ year old previous phase 2 foreign trial from Lohr’s study with cell encapsulation therapy then we must also attribute the treatment to the other 4 tumors who GREW in patients while receiving treatment.

There were literally 4 patient’s who’s tumors were reduced in size and 4 patients who’s tumors GREW. With median growth outweighing median reduction. This is what we call statistically insignificant data.

GO READ THE STUDY DON’T BELIEVE THE WEBSITE AND $40,000 video made to sell a penny stock not educate the public.

FDA does not even come close to considering this appropriate for phase 2 and probably won’t even let it go to phase 1. FDA might consider letting animal studies proceed, but I imagine this will be a total and complete failure.

1.) ACCORDING TO PMCB. This is a completely new manufactured product with many differences from 20+ year old treatment. Therefore, It cannot be used to determine efficacy of the new cells. PMCB is saying it’s new and trying to use old data from old method of cells. FDA doesn’t roll that WAY.

2.) not enough patients in both previous studies combined. The data suggests even with the small patient studies, that this treatment is not effective when compared to current treatments available in 2020.

3.) FDA doesn’t overlook reputation of a company. A poor reputation in the industry such as no prior biotech experience or impressions of a scam will cause them to spend more time evaluating and ultimately not allowing CTs to go forward especially if they believe it will not advance the CURRENT treatments either in place or in advanced CTs such as triple combination therapy and immune therapy alone.

4.) ITS ALREADY SOOOO OBVIOUS THIS IS A PUMP AND DUMP FROM THE CONSTANT VOLATILE market Schizophrenia such as STUTTGART’s market continually up 40% then down 50% the next day. All while any and all buying will ALWAYS BE MATCHED BY INSIDE SELLING

5.) the investor is trapped. Those hopeful won’t sell at a loss and left holding the bag. CEO knows this and relies on SH longs who will continue to hold allowing them to continue to introduce new NOVICE buyers while they continue to sell off EVERY last share they are vested in their salary package. It’s a modern day pump and dump that doesn’t die in a few years. It’s takes decades.

If anyone is lucky enough to get out with even a 50% loss then consider them the lucky ones. This company will continue to dive over time never again reaching even .015 again. CEO took a big gamble submitting something he knew would never make it to Phase 2b. It’s called FRAUD! ... did I mention the CEO is defendant to FRAUD in 2 separate cases in his home town of Orange County, Ca. Occourts.org. Spend the buck and look up the CEO of a public company. It’s your right.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News